Discover other firms ranked in Life Sciences

2
Band 2
Morrison Foerster
2
Morrison Foerster
8 Years Ranked
View profile
Nishimura & Asahi
2
Nishimura & Asahi
7 Years Ranked
View profile
Baker McKenzie
2
Baker McKenzie
8 Years Ranked
View profile
3
Band 3
Abe, Ikubo & Katayama
3
Abe, Ikubo & Katayama
8 Years Ranked
View profile
TMI Associates
3
TMI Associates
8 Years Ranked
View profile
Jones Day
3
Jones Day
8 Years Ranked
View profile

Chambers Review

Provided by Chambers

Life Sciences - Japan

3
Band 3

What the Team is Known For

Squire Patton Boggs has an established track record of handling work for Japanese pharmaceutical, medical device and biotechnology companies. The firm's areas of focus include advising on licensing and development agreements. The team additionally advises both Japanese and international life sciences clients regarding acquisitions and joint ventures in the sector and on related regulatory issues.

Strengths

The partner and his team are amazing with their industry and commercial acumen. The insights, advice and support we receive from them cannot be understated in terms of value.

The team have consistently impressed us with their ability to grasp both the technical and market-facing dimensions of our business. The guidance we receive goes well beyond traditional advice.

Notable practitioners

Stephen Chelberg heads the firm's life sciences practice and handles cross-border M&A, joint ventures and financing in this space. He also ably advises clients on Japanese market entry and commercial agreements.

 

Stephen Chelberg has a great personality and is fluent in Japanese. He is a most reliable and wonderful lawyer.

 

Steve has not only been a great legal mind on matters, but has also become an essential adviser to us as we attempt to navigate market entry into Japan.

Ranked Lawyers at
Squire Patton Boggs

Provided by Chambers
Filter by
Band

Japan

Life Sciences

3
Stephen Chelberg
3
Band 3